Clinical Trial Update: Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for intravenous fenretinide emulsion in relapsed/refractory peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• fenretinide emulsion (fenretinide)

Snippet

Sponsor: CerRx, Inc. | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: UNKNOWN